Table 2. The cellular expression of MUC1 SP domain on MUC1 positive tumor cell-lines and primary naïve cells.

Human tumor Cell-lines Primary cells	Origin	Mouse control	H23	SPmAb-6	SPmAb-2.1	Rabbit control		R23IgG
		Fluorescence intensity (Geometric mean)
ES-2	Ovarian Carcinoma	234	232	248	237	251	247
OVCAR-3	Ovarian Carcinoma	370	4456	11440	1019	418	10800
MCF7	Breast Carcinoma	230	1004	1091	413	236	4705
MDA-453	Breast Carcinoma	182	580	559	290	165	2443
MDA-231	Breast Carcinoma	245	966	591	312	215	1931
Raji	B-Lymphoblastic Leukemia	131	303	307	179	128	519
Ramos	B-Lymphocytic Leukemia	198	558	660	402	111	384
U266	Multiple Myeloma	485	2039	661	574	471	1716
RPMI 8226	Multiple Myeloma	745	2585	1190	1154	738	2331
ARH-77	Plasma cell Leukemia	176	668	691	439	161	3966
SK-mel-28	Melanoma	117	119	114	112	113	117
SK-mel-1	Melanoma-Metastasis	352	325	342	345	350	348
Naïve epithelial cells	Mammary epithelial cells (HMEC)	319	338	328	314	380	343
		Fluorescence intensity (% Positive staining) 1
T-Lymphocytes (CD3+)	White blood cells	0	0.135	0.062	0.097	0.043	0.038
B-Lymphocytes (CD20+)	White blood cells	0	0.031	0.003	0.009	0.003	0.41
Myeloid (CD14+)	White blood cells	0.003	0.463	0.325	0.23	0.026	0.032

¹% of positive staining was applies in cell which undergo double staining.